Equity Research Database

Institutional Investment Pitches

Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.

Home Letters Funds Account

The Baird Chautauqua International Growth Fund's investment thesis on WuXi Biologics (Cayman) Inc. ($2269.HK) — Q4 2025 | Buyside Digest

All Pitches

View Letter Analysis

$2269.HKNASDAQWuXi Biologics (Cayman) Inc.

BULL

The Baird Chautauqua International Growth Fund—2269.HK

Fund Letter

Q4 2025

Published January 1, 2026

View Fund Profile

$50.65USD

+2.7% vs last month

$34.10Pitched

+48.5% since pitch

Market Cap$169.9B

P/E (TTM)N/A

52-Wk RangeN/A

Div. YieldN/A

Technical Chart

From the Fund Letter

In Q4 2025, global equity markets concluded a strong year, characterized by a major shift where international equities outperformed U.S. equities for the full year. The Baird Chautauqua...

— Haicheng Li, CFA

BSD Research Exclusive

Unlock Full Institutional Investment Theses

Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($55/mo) and Pro subscribers.

6,000+ Institutional Pitches

Proprietary AI Analysis

100 Letter Unlocks/Cycle

SUBSCRIBE TO BSD RESEARCH ($55/MO)Compare All Plans

Already a Research or Pro subscriber? Sign In

◆ Keep Reading

What other investors think about $2269.HK, and what else The Baird Chautauqua International Growth Fund is buying.

Other pitches on $2269.HK

Other investors who've written on WuXi Biologics (Cayman) Inc.

Baillie Gifford -International GrowthBULL

Pitched Apr 1, 2025

Wuxi Biologics is highlighted as a top contributor among Chinese holdings that have executed well operationally. It continues to...

View all $2269.HK pitches →